Martin Schaller Selected Research

amorolfine

12/2017	Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
10/2015	Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
11/2009	Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Schaller Research Topics

Disease

39	Infections 01/2022 - 04/2001
25	Neoplasms (Cancer) 04/2021 - 10/2008
11	Inflammation (Inflammations) 01/2021 - 04/2007
11	Melanoma (Melanoma, Malignant) 10/2020 - 08/2009
10	Rosacea (Acne Rosacea) 10/2021 - 07/2010
8	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 01/2006
7	Hypersensitivity (Allergy) 01/2021 - 08/2009
5	Candidiasis (Moniliasis) 02/2022 - 06/2003
5	Necrosis 02/2022 - 08/2002
4	Thrombosis (Thrombus) 01/2018 - 01/2014
4	Autoimmune Diseases (Autoimmune Disease) 02/2015 - 08/2009
3	Neoplasm Metastasis (Metastasis) 04/2021 - 01/2019
3	Erythema 05/2018 - 01/2007
3	Sepsis (Septicemia) 01/2018 - 01/2012
3	Onychomycosis (Tinea Unguium) 12/2017 - 11/2009
2	Carcinoma (Carcinomatosis) 06/2022 - 10/2011
2	Bacterial Infections (Bacterial Infection) 01/2022 - 08/2009
2	Telangiectasis (Telangiectasia) 08/2021 - 03/2014
2	Blepharitis 08/2021 - 03/2014
2	Meibomian Gland Dysfunction 08/2021 - 03/2014
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 10/2009
2	Colitis 10/2019 - 01/2019
2	Contact Dermatitis (Eczema, Contact) 01/2019 - 08/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 10/2011
2	Mycoses (Diseases, Fungus) 06/2016 - 06/2003
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016 - 01/2014
2	Bullous Pemphigoid (Pemphigoid) 12/2015 - 07/2015
2	Atherosclerosis 09/2014 - 03/2010
2	Acne Vulgaris 05/2012 - 01/2006
2	Glioblastoma (Glioblastoma Multiforme) 10/2011 - 10/2008
2	Pyoderma Gangrenosum 10/2011 - 01/2009

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 02/2022 - 04/2002
11	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2008
6	Peptide Hydrolases (Proteases)FDA Link 11/2008 - 04/2002
5	InterferonsIBA 02/2022 - 04/2007
5	Ivermectin (Mectizan)FDA Link 08/2021 - 11/2003
5	Peptides (Polypeptides)IBA 01/2019 - 11/2008
5	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016 - 01/2002
4	Interleukin-17 (Interleukin 17)IBA 02/2022 - 07/2011
4	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021 - 10/2008
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020 - 02/2011
4	Ciclopirox (Loprox)FDA LinkGeneric 12/2017 - 06/2003
4	Messenger RNA (mRNA)IBA 09/2017 - 04/2001
4	Virulence Factors (Pathogenicity Factors)IBA 01/2009 - 04/2002
4	Aspartic Acid ProteasesIBA 11/2008 - 02/2002
3	Interleukin-22 (IL-22)IBA 02/2022 - 07/2011
3	Transcription Factors (Transcription Factor)IBA 04/2021 - 02/2011
3	Mitogen-Activated Protein KinasesIBA 10/2020 - 02/2011
3	Doxycycline (Periostat)FDA LinkGeneric 02/2020 - 11/2011
3	Immunoglobulin A (IgA)IBA 02/2020 - 09/2016
3	InterleukinsIBA 01/2019 - 08/2002
3	bifonazoleIBA 12/2017 - 11/2009
3	amorolfineIBA 12/2017 - 11/2009
3	AntibodiesIBA 09/2017 - 04/2005
3	Metronidazole (Metric)FDA LinkGeneric 08/2017 - 11/2003
3	Isotretinoin (Accutane)FDA LinkGeneric 09/2016 - 07/2010
3	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2014
3	Interleukin-6 (Interleukin 6)IBA 11/2014 - 09/2004
3	Interleukin-8 (Interleukin 8)IBA 08/2010 - 08/2002
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2010 - 08/2002
2	talimogene laherparepvecIBA 06/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021 - 01/2021
2	PhosphatidylserinesIBA 12/2021 - 01/2014
2	IronIBA 12/2021 - 09/2002
2	Fluorescein (Funduscein)FDA LinkGeneric 08/2021 - 03/2014
2	Antifungal AgentsIBA 06/2021 - 06/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2021 - 01/2005
2	NitrogenIBA 01/2021 - 04/2005
2	Immune Checkpoint InhibitorsIBA 12/2020 - 10/2019
2	Adenosine Triphosphate (ATP)IBA 08/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 08/2020 - 10/2019
2	CalciumIBA 08/2020 - 01/2013
2	CarbohydratesIBA 01/2020 - 04/2005
2	AntigensIBA 01/2019 - 06/2003
2	Thrombin FDA Link 01/2018 - 01/2014
2	VemurafenibIBA 10/2017 - 01/2013
2	ElementsIBA 09/2017 - 01/2014
2	Antimicrobial PeptidesIBA 09/2017 - 01/2013
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2016 - 01/2014
2	CollagenIBA 01/2016 - 09/2014
2	CeramidesIBA 01/2016 - 01/2014
2	IntegrinsIBA 01/2016 - 08/2015
2	Fluconazole (Zonal)FDA LinkGeneric 10/2015 - 01/2008
2	Laminin (Merosin)IBA 07/2015 - 01/2014
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2015 - 07/2007
2	Interleukin-12 (IL 12)IBA 02/2015 - 12/2004
2	Interleukin-23 (Interleukin 23)IBA 02/2015 - 10/2011
2	Interleukin-10 (Interleukin 10)IBA 04/2014 - 12/2004
2	Type I Tumor Necrosis Factor ReceptorsIBA 02/2013 - 08/2009
2	Phosphotransferases (Kinase)IBA 01/2013 - 10/2008
2	LigandsIBA 01/2012 - 08/2002
2	Prednisolone (Predate)FDA LinkGeneric 08/2009 - 07/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2006 - 01/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004 - 09/2004
2	ChemokinesIBA 09/2004 - 04/2002

Therapy/Procedure

30	Therapeutics 02/2022 - 01/2002
6	Immunotherapy 01/2021 - 02/2014
2	Radiotherapy 10/2020 - 07/2016
2	Aftercare (After-Treatment) 08/2017 - 01/2009